CBSNews.com
/
CBS Evening News
/
CBS This Morning
/
60 Minutes
/
Sunday Morning
/
Face the Nation
/
48 Hours
Markets
Investing
Tech
Leadership
Small Business
Saving
Spending
Retirement
Video
Log In
Log In
Join CBSNews.com
Sign in with
My Profile
Manage my newsletter subscriptions
Update my e-mail address
Change my password
Log Out
Get
Recent Quotes
View Full List
/
Top Indices
Dow Jones Industrials
Nasdaq Composite
S&P 500
NYSE Composite
NYSE MKT Composite
BioMarin Pharmaceuticals, Inc.
(NQ:
BMRN
)
57.21
USD
UNCHANGED
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Options
Historical Prices
Chart
Chart
News
All News
Press Releases
Related Stories
Blogs
Podcasts
SEC Filings
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
58.30
Bid (Size)
37.01 (100)
Ask (Size)
60.00 (1000)
Prev. Close
57.21
Today's Range
57.16 - 58.60
52wk Range
35.99 - 71.56
Shares Outstanding
139,010,175
Dividend Yield
N/A
Top News
More News
CORRECTED-UPDATE 1-Niche drugmaker ViroPharma attracts takeover interest - sources
June 19, 2013
(In June 17 item, corrects in 3rd paragraph to show that ViroPharma is 19 years old)
Read More
category
companyNews
from
Reuters: Company News
UPDATE 1-Niche drugmaker ViroPharma attracts takeover interest -sources
June 17, 2013
NEW YORK, June 17 (Reuters) - ViroPharma Inc, a drug maker specializing in rare diseases, is attracting preliminary acquisition interest from several pharmaceutical companies, according to three people...
Read More
category
companyNews
from
Reuters: Company News
Orphan drugmaker ViroPharma attracts takeover interest -sources
June 17, 2013
NEW YORK, June 17 (Reuters) - ViroPharma Inc is attracting preliminary interest from several pharmaceutical companies about buying the orphan drugmaker, according to three people familiar with the...
Read More
category
companyNews
from
Reuters: Company News
StockCall Study on BMRN, DCTH, ASTX, and AKRX
June 14, 2013
from
ACCESSWIRE
More News
Read More
Ongoing Clinical Trials Reveal Groundbreaking Results - Research Report on Alexion, BioMarin, Onyx, Questcor, and ImmunoGen
June 14, 2013
from
PR Newswire
UPDATE: Jean-Jacques Bienaime, CEO of BioMarin, to Present at the Goldman Sachs Global Healthcare Conference
June 06, 2013
from
GlobeNewswire News Releases
BioMarin to Present at the Goldman Sachs Global Healthcare Conference
June 06, 2013
from
GlobeNewswire News Releases
Critical Alerts For General Motors, SAP, Blackberry, BioMarin Pharmaceutical, and Trimble Navigation Released By InvestorsObserver
June 05, 2013
from
PR Newswire
BioMarin Initiates Phase 3 Trial for PEG-PAL for the Treatment of PKU
June 05, 2013
from
GlobeNewswire News Releases
Upgrade Alert for BioMarin Pharmaceutical (BMRN)
June 04, 2013
from
Comtex SmarTrend® News Briefs
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here